Novel Infringed Braintree's Laxative Patent, Judge Rules
A New Jersey federal judge ruled Friday that Novel Laboratories Inc., a company that planned to make a generic of the colon-cleansing drug Suprep, infringed Braintree Laboratories Inc.'s patent on the...To view the full article, register now.
Already a subscriber? Click here to view full article